Sartorius New Software Solution for Pharma Industry
Sartorius Stedim Biotech (SSB), a leading global supplier to the biopharmaceutical industry, announced the launch of Active Dashboard 2, an advanced software solution.
Offered by its subsidiary, Sartorius Stedim Data Analytics, the release features significant improvements for applications in biopharmaceutical, pharmaceutical, and other manufacturing industries. Delivering in-depth insights into process performance across the manufacturing network, managerial staff can take evidence-based proactive actions that will help to achieve better timely decisions, ensuring superior manufacturing success.

Active Dashboard 2 provides real-time process information from multivariate SIMCA-online data analysis systems — part of the Umetrics Suite of Data Analytics Solutions. The Active Dashboard 2 software now offers innovative data visualisation options, such as easy self-service visual analytics with cross-filtering to reduce the involvement of data analysis experts; role-based display of relevant information; and the ability to connect to other data sources.
“The improvements in Active Dashboard 2 will help our customers to enhance their competitive advantage – both globally and locally. With in-depth insights into data of their manufacturing processes, they can significantly improve the decision-making process,” said Jonas Elfving, product manager at Sartorius Stedim Data Analytics.
2026-08-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kraton Announces Strategic Plan to Streamline Polymer Operations in Berre, France
-
Iran Closes Strait of Hormuz to All Vessels: Global Chemical Trade Gets Choked
-
Behind Japan's Tungsten Hexafluoride Crisis: Can China's Electronic Specialty Gases Seize a New Opportunity?
-
TSMC, Samsung, and SK Hynix Scramble for Electronic-Grade Hydrofluoric Acid as High-End Supply Tightens; Some Suppliers Raise Prices by 30% This Year
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
U.S. EPA Targets Perchlorate: A New Safety Line Drawn in Drinking Water Standards
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
Australia Launches Anti-Circumvention Trade Probe into China’s 2,4-D Supply Chain
Recommend Reading
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
Arkema Invests $60 Million to Upgrade its US FluoroSpecialties Production Unit
-
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou
-
MTBE Market Shows Slight Fluctuations
-
Negative Factors Suppress Adipic Acid Market Decline
-
This Week's Isopropyl Alcohol Market Prices Slightly Increased (9.1-9.5) in China
-
November Cost and Demand Game, Polyester Bottle Chip Prices Fluctuate
-
This week, the price of sodium metabisulfite in China has fallen (9.1-9.5)